Serially transplantable chemically induced rat islet cell tumor - PubMed
Serially transplantable chemically induced rat islet cell tumor
W L Chick et al. Endocrinology. 1980 Oct.
Abstract
A serially transplantable, chemically induced pancreatic islet cell tumor was developed in Lewis rats. The original tumor was induced by the administration of streptozotocin and nicotinamide. It was subsequently maintained by ip or sc transplantation of tissue fragments into recipient animals. Tumors generally grew to 0.5--2.0 cm in diameter within 3--4 months of transplantation. They were well encapsulated, without gross evidence of metastasis. Peroxidase immunocytochemical staining revealed a predominance of insulin-positive cells. Somatostatin-positive cells were also present and varied widely in numbers between different tumors. In addition, small numbers of glucagon-positive cells were observed in all of the tumors. On electron microscopy, cells containing secretory granules, indistinguishable from nonneoplastic beta-cells, were most abundant. Other granulated cells were also observed, but the granule morphology was not identical to that of any of the other classically described islet cell types. Tumor extracts contained an average of 3260 micrograms insulin, 22.6 micrograms somatostatin, and 0.84 micrograms glucagon per g wet wt of tissue. Tumors caused marked, progressive hypoglycemia in recipients, with plasma glucose levels frequently falling below 30 mg/dl before death. Furthermore, the recipients' islets were markedly reduced in size due to a decreased beta-cell volume.
Similar articles
-
Masiello P, Wollheim CB, Gori Z, Blondel B, Bergamini E. Masiello P, et al. Toxicol Pathol. 1984;12(3):274-80. doi: 10.1177/019262338401200311. Toxicol Pathol. 1984. PMID: 6151238
-
Kazumi T, Hirose Y, Ishihara K, Makimura H, Yoshino G, Utsumi M, Baba S. Kazumi T, et al. Horm Metab Res. 1986 Sep;18(9):584-6. doi: 10.1055/s-2007-1012380. Horm Metab Res. 1986. PMID: 3023223
-
Induction and differentiation of exocrine pancreatic tumors in the rat.
Rao MS, Reddy JK. Rao MS, et al. Exp Pathol. 1985;28(2):67-87. doi: 10.1016/s0232-1513(85)80018-9. Exp Pathol. 1985. PMID: 3899705 Review. No abstract available.
Cited by
-
Flatt PR, Tan KS, Bailey CJ, Powell CJ, Swanston-Flatt SK, Marks V. Flatt PR, et al. Br J Cancer. 1986 Oct;54(4):685-92. doi: 10.1038/bjc.1986.227. Br J Cancer. 1986. PMID: 2877684 Free PMC article.
-
Philippe J, Chick WL, Habener JF. Philippe J, et al. J Clin Invest. 1987 Feb;79(2):351-8. doi: 10.1172/JCI112819. J Clin Invest. 1987. PMID: 2879852 Free PMC article.
-
Masiello P, Wollheim CB, Blondel B, Renold AE. Masiello P, et al. Diabetologia. 1983 Jan;24(1):30-7. doi: 10.1007/BF00275944. Diabetologia. 1983. PMID: 6131005
-
Flatt PR, Abrahamsson H, Arkhammar P, Berggren PO, Rorsman P, Swanston-Flatt SK. Flatt PR, et al. Br J Cancer. 1988 Jul;58(1):22-9. doi: 10.1038/bjc.1988.154. Br J Cancer. 1988. PMID: 2844219 Free PMC article.
-
Glucagon-like peptide-1, a new hormone of the entero-insular axis.
Orskov C. Orskov C. Diabetologia. 1992 Aug;35(8):701-11. Diabetologia. 1992. PMID: 1324859 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical